(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Refractory Angina pipeline constitutes 3+ key companies continuously working towards developing 3+ Refractory Angina treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Refractory Angina Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]
Market activity has picked up, with meme stocks outperforming broader market trends. Interest in these stocks has surged, largely driven by the online influencer known as “Roaring Kitty,” who ignited a social media frenzy on Reddit Inc. (NYSE: RDDT) involving GameStop (NYSE: GME) previously. Currently trending stocks on Yahoo Finance include GameStop (NYSE: GME), AMC Entertainment (NYSE: […]
DelveInsight’s, “Metastatic-Liver-Cancer Pipeline Insight 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Metastatic-Liver-Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cancer Cachexia pipeline constitutes 12+ key companies continuously working towards developing 15+ Cancer Cachexia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Cancer Cachexia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]
DelveInsight’s, “Glioblastoma Pipeline Insight, 2024,” report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. […]
DelveInsight’s, “Gastric Cancer Pipeline Insight 2024” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the […]
Non-Alcoholic Steatohepatitis Pipeline Insight 2024 Sagimet Biosciences, Terns, Sinew Pharma, Madrigal Pharmaceuticals, Hepion Pharmaceuticals, Poxel SA, Pfizer, CytoDyn, Altimmune, Oramed, PharmaKing, Can-Fite Biopharma, Cirius Therapeutics As per DelveInsight’s assessment, globally, about 100+ key pharma and biotech companies are working on 150+ pipeline drugs in the Non-Alcoholic Steatohepatitis (NASH) therapeutics landscape based on different Routes of […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 37+ key companies continuously working towards developing 40+ EGFR Non Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The EGFR Non Small Cell Lung […]
Identifying biotech stocks with the potential to deliver superior returns is no easy feat. There are specific milestones that companies can achieve to signal positive momentum to investors. For example, smaller biotech companies may have received the nod from regulatory authorities such as the FDA, or new breakthroughs from clinical trials, to offer a compelling […]
PD-1 and PD-L1 Inhibitors Market PD-1 and PD-L1 inhibitor companies are Buzzard Pharmaceuticals, AstraZeneca, Daiichi Sankyo, Inc., OncoC4, Inc., BioNTech SE, Incyte, MacroGenics, Novartis, GlaxoSmithKline, Phanes Therapeutics, Compass Therapeutics, HUYABIO International, LLC., Bristol-Myers Squibb, Chugai Pharma USA, Bayer, Istari Oncology, Calico Life Sciences, AbbVie, NeoImmuneTech, Kartos Therapeutics, Inc., CellSight Technologies, Inc., Glenmark Specialty S.A., Jounce […]
